Gemmer Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12
| Closed | – | – | 324 |
|
|
2022
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 1238 |
|
|
2021
Q4 | $1K | Sell |
12
-13
| -52% | -$1.08K | ﹤0.01% | 1212 |
|
|
2021
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 1104 |
|
|
2021
Q2 | $4K | Hold |
25
| – | – | ﹤0.01% | 1164 |
|
|
2021
Q1 | $3K | Sell |
25
-244
| -91% | -$29.3K | ﹤0.01% | 1247 |
|
|
2020
Q4 | $41K | Buy |
269
+219
| +438% | +$33.4K | 0.01% | 265 |
|
|
2020
Q3 | $4K | Sell |
50
-25
| -33% | -$2K | ﹤0.01% | 940 |
|
|
2020
Q2 | $6K | Sell |
75
-50
| -40% | -$4K | ﹤0.01% | 770 |
|
|
2020
Q1 | $5K | Buy |
+125
| New | +$5K | ﹤0.01% | 739 |
|
|
2019
Q1 | – | Sell |
-200
| Closed | -$6K | – | 1400 |
|
|
2018
Q4 | $6K | Hold |
200
| – | – | ﹤0.01% | 818 |
|
|
2018
Q3 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 744 |
|